There have been 50 recent insider transactions recorded for NeuBase Therapeutics, Inc. (NBSE), including 34 buys and 10 sells. Total insider buying was valued at $6.03M and total insider selling at $715.23K.
Notable insiders with recent activity include Symetryx Corp, Stephan Dietrich A, Branning Todd P.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NBSE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2023-09-18 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
50,000 |
$1.19 |
$59.5K |
- |
| 2023-09-15 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
103,337 |
$1.26 |
$130.2K |
50,000 |
| 2023-09-14 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
129,108 |
$1.44 |
$185.92K |
153,337 |
| 2023-09-11 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
3,376 |
$1.44 |
$4.86K |
472,926 |
| 2023-09-08 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
128,847 |
$1.53 |
$197.14K |
476,302 |
| 2023-09-07 |
Symetryx Corp |
10 Percent Owner |
Informative Sell |
74,852 |
$1.80 |
$134.73K |
605,149 |
| 2023-09-01 |
Symetryx Corp |
10 Percent Owner |
Informative Buy |
61,076 |
$0.98 |
$59.73K |
680,081 |
| 2023-08-23 |
Symetryx Corp |
10 Percent Owner |
Disposition |
- |
- |
- |
3,800 |
| 2023-08-23 |
Symetryx Corp |
10 Percent Owner |
Disposition |
- |
- |
- |
80,973 |
| 2023-08-02 |
Stephan Dietrich A |
10 Percent Owner, Officer: Founder and CEO |
Option Exercise (Sell) |
93,234 |
$0.02 |
$2.05K |
- |
| 2023-03-16 |
Branning Todd P. |
Chief Financial Officer |
RSU Award |
54,200 |
- |
- |
84,200 |
| 2023-03-16 |
Stephan Dietrich A |
10 Percent Owner, Officer: CEO and Director |
RSU Award |
153,000 |
- |
- |
153,000 |
| 2023-02-13 |
Stephan Dietrich A |
10 Percent Owner, Officer: President and CEO |
Option Exercise |
655,000 |
- |
- |
1,471,775 |
| 2022-12-31 |
Symetryx Corp |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-11-03 |
Branning Todd P. |
Chief Financial Officer |
RSU Award |
200,000 |
- |
- |
200,000 |
| 2022-09-28 |
Stephan Dietrich A |
CEO |
Option Exercise (Sell) |
750,000 |
$0.00 |
$825.00 |
2,519,680 |
| 2022-09-09 |
Goldstein Dov A Md |
Director |
RSU Award |
37,600 |
$0.60 |
$22.56K |
37,600 |
| 2022-09-09 |
Prendergast Franklyn G |
Director |
RSU Award |
37,600 |
$0.60 |
$22.56K |
37,600 |
| 2022-09-09 |
Richman Eric I |
Director |
RSU Award |
37,600 |
$0.60 |
$22.56K |
37,600 |
| 2022-09-09 |
Ende Eric J |
Director |
RSU Award |
37,600 |
$0.60 |
$22.56K |
37,600 |
| 2022-09-09 |
Mcdougall Gerald J |
Director |
RSU Award |
37,600 |
$0.60 |
$22.56K |
37,600 |
| 2022-03-30 |
Mann William Roland |
Chief Operating Officer |
Informative Buy |
6,200 |
$1.92 |
$11.9K |
11,200 |
| 2022-03-18 |
Branning Todd P. |
Chief Financial Officer |
Informative Buy |
10,000 |
$1.81 |
$18.1K |
30,000 |
| 2022-03-16 |
Branning Todd P. |
Chief Financial Officer |
Informative Buy |
10,000 |
$1.62 |
$16.2K |
10,000 |
| 2022-03-04 |
Richman Eric I |
Director |
Informative Buy |
1,000 |
$1.62 |
$1.62K |
44,960 |
| 2022-03-01 |
Richman Eric I |
Director |
Informative Buy |
1,580 |
$1.58 |
$2.5K |
42,660 |
| 2022-01-24 |
Rojas-caro Sandra |
Chief Medical Officer |
RSU Award |
44,592 |
$1.58 |
$70.46K |
44,592 |
| 2022-01-24 |
Stephan Dietrich A |
10 Percent Owner, Officer: President and CEO |
RSU Award |
306,000 |
$1.58 |
$483.48K |
306,000 |
| 2022-01-24 |
Mann William Roland |
Chief Operating Officer |
RSU Award |
60,180 |
$1.58 |
$95.08K |
60,180 |
| 2022-01-10 |
Branning Todd P. |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-01-10 |
Branning Todd P. |
Chief Financial Officer |
RSU Award |
300,000 |
$2.52 |
$756K |
300,000 |
| 2022-01-01 |
Ende Eric J |
Director |
Unknown |
- |
- |
- |
- |
| 2022-01-01 |
Ende Eric J |
Director |
RSU Award |
165,803 |
$2.95 |
$489.12K |
165,803 |
| 2021-12-31 |
Stephan Dietrich A |
10 Percent Owner, Officer: President and CEO |
Option Exercise |
42,250 |
$0.00 |
$42.25 |
66,775 |
| 2021-08-19 |
Goldstein Dov A Md |
Director |
RSU Award |
38,135 |
$3.36 |
$128.13K |
38,135 |
| 2021-08-19 |
Prendergast Franklyn G |
Director |
RSU Award |
38,135 |
$3.36 |
$128.13K |
38,135 |
| 2021-08-19 |
Richman Eric I |
Director |
RSU Award |
38,135 |
$3.36 |
$128.13K |
38,135 |
| 2021-08-19 |
Mcdougall Gerald J |
Director |
RSU Award |
38,135 |
$3.36 |
$128.13K |
38,135 |
| 2021-08-16 |
Mann William Roland |
COO |
RSU Award |
25,000 |
$3.49 |
$87.25K |
25,000 |
| 2021-06-18 |
Goldstein Dov A Md |
Director |
Informative Buy |
8,000 |
$4.75 |
$38K |
30,000 |
| 2021-05-24 |
Rojas-caro Sandra |
Officer |
Unknown |
- |
- |
- |
- |
| 2021-05-24 |
Rojas-caro Sandra |
Chief Medical Officer |
RSU Award |
280,000 |
$5.01 |
$1.4M |
280,000 |
| 2021-05-24 |
Motesharei Kianoush |
Officer |
Unknown |
- |
- |
- |
- |
| 2021-05-24 |
Motesharei Kianoush |
See Remarks |
RSU Award |
250,000 |
$5.01 |
$1.25M |
250,000 |
| 2021-05-11 |
Mcdougall Gerald J |
Director |
Unknown |
- |
- |
- |
- |
| 2021-05-11 |
Mcdougall Gerald J |
Director |
RSU Award |
92,219 |
$4.91 |
$452.8K |
92,219 |
| 2021-04-26 |
Goldstein Dov A Md |
Director |
Informative Buy |
12,000 |
$5.00 |
$60K |
22,000 |
| 2021-04-26 |
Richman Eric I |
Director |
Informative Buy |
5,000 |
$5.00 |
$25K |
41,080 |
| 2021-04-26 |
Stephan Dietrich A |
10 Percent Owner, Officer: President and CEO |
Informative Buy |
12,000 |
$5.00 |
$60K |
24,525 |
| 2021-04-26 |
Mann William Roland |
COO |
Informative Buy |
5,000 |
$5.00 |
$25K |
5,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
